DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Comparison of Absorbability Between Calcium Tablet and Calcium Ion Water

Information source: Hiroshima University
ClinicalTrials.gov processed this data on August 20, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Healthy

Intervention: Calcium tablet (Dietary Supplement); Calcium ion water (250mg) (Dietary Supplement); Calcium ion water (125mg) (Dietary Supplement)

Phase: N/A

Status: Completed

Sponsored by: Hiroshima University

Official(s) and/or principal investigator(s):
Fumiko Higashikawa, PhD, Principal Investigator, Affiliation: Hiroshima University

Summary

The purpose of this study is to evaluate the absorbability of calcium tablet and calcium ion water.

Clinical Details

Official title: A Randomized, Double-blind, Crossover Study to Compare the Absorbability Between Calcium Tablet and Calcium Ion Water

Study design: Allocation: Randomized, Endpoint Classification: Pharmacokinetics Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Prevention

Primary outcome: Serum calcium profile (including AUC, Cmax, and Tmax)

Eligibility

Minimum age: 55 Years. Maximum age: 70 Years. Gender(s): Female.

Criteria:

Inclusion Criteria:

- Postmenopausal females

Exclusion Criteria:

- Taking medicines or functional food that affect serum calcium levels

- Diseases that affect bone

- Renal or hepatic dysfunction

- Heart disease

- Participation in any clinical trial within 90 days of the commencement of the trial

Locations and Contacts

Hiroshima University, Hiroshima, 734-8551, Japan
Additional Information

Starting date: November 2012
Last updated: March 26, 2013

Page last updated: August 20, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017